Businessinsider.com 5
However, the flagship DFT patch lacks independent clinical evidence for its specific claims, the DSSRC found Le-Vel and its promoters used inappropriate income and health claims, and most Brand Promoters earn very little
conducted target trial emulations comparing dual GLP-1/GIP agonists to GLP-1 monotherapy in patients with type 2 diabetes, finding that dual agonists were linked to numerically lower risks of MALOs, although confidence intervals overlapped, suggesting that extended observation period and larger patient cohorts may be needed to definitively establish comparative effectiveness [61]
Because the half-life of semaglutide is 7 days (165 hours), it reaches steady state in 4-5 weeks
And while GLP-1 medications like semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound) have taken the weight loss world by storm, here's what most most people are missing: these medications work significantly better when your hormones are also being addressed
Jacobs PL, Goldstein ER, Blackburn W, Orem I, Hughes JJ: Glycine propionyl-L-carnitine produces enhanced anaerobic work capacity with reduced lactate accumulation in resistance trained males
